A. A. Antonov, S. Vostrukhin, A. V. Volzhanin, A. A. Vitkov, A. M. Akimov, I. I. Asinovskova
{"title":"Influence of prostaglandin analogues on intraocular pressure fluctuations in body position change","authors":"A. A. Antonov, S. Vostrukhin, A. V. Volzhanin, A. A. Vitkov, A. M. Akimov, I. I. Asinovskova","doi":"10.32364/2311-7729-2022-22-2-103-107","DOIUrl":null,"url":null,"abstract":"Aim: to assess the effects of prostaglandin F2a analogues on intraocular pressure (IOP) fluctuations when changing body position. Patients and Methods: thirty-eight patients (50 eyes) with newly diagnosed primary open-angle glaucoma (POAG). Patients were examined before and one month after prescribing travoprost, a prostaglandin F2a analogue. During the examination, IOP was measured by Icare pro rebound tonometry and applanation tonometry (corneal-compensated IOP/ccIOP and Goldmann-correlated IOP/IOPg) in a sitting position. Next, IOP was measured by Icare tonometer twice with a 5-min interval in a supine position. Finally, IOP was measured by Icare tonometry and applanation tonometry (IOPcc, IOPg) in the sitting position. Results: baseline IOPcc, IOPg, and IOP measured by Icare were 25.4±3.2 mm Hg, 25.7±2.3 mm Hg, and 22.9±3.4 mm Hg, respectively. IOP levels (Icare tonometry) in the supine position were 23.7±3.3 mm Hg and 24.0±3.3 mm Hg, respectively. In repeated measurements in the sitting position, IOPcc, IOPg, and IOP measured by Icare were 25.4±3.2 mm Hg, 25.7±2.4 mm Hg, and 22.3±3.4 mm Hg. One month after starting treatment with travoprost, IOPcc, IOPg, and IOP measured by Icare reduced to 18.2±2.7 mm Hg, 18.2±1.8 mm Hg, and 16.6±2.5 mm Hg, respectively. IOP levels (Icare tonometry) in the supine position were 17.3±2.8 mm Hg and 17.2±2.7 mm Hg, respectively. In repeated measurements in the sitting position, IOPcc, IOPg, and IOP measured by Icare were 18.0±2.3 mm Hg, 18.4±1.8 mm Hg, and 16.2±2.5 mm Hg, respectively. When transiting in a supine position, the differences in IOP levels were 0.83±1.04 mm Hg at baseline and 0.77±1.41 mm Hg after one month. When transiting in a sitting position, the differences in IOP levels were 1.66±1.24 mm Hg at baseline and 0.99±0. 98 mm Hg after one month. Conclusion: travoprost as a starting monotherapy for POAG provides a long-lasting IOP reduction and minimizes its fluctuations when changing body position Keywords: glaucoma, intraocular pressure, body position, rebound tonometry, prostaglandin analogue, travoprost. For citation: Antonov A.A., Vostrukhin S.V., Volzhanin A.V. et al. Influence of prostaglandin analogues on intraocular pressure fluctuations in body position change. Russian Journal of Clinical Ophthalmology. 2022;22(2):103–107 (in Russ.). DOI: 10.32364/2311-7729-2022- 22-2-103-107.","PeriodicalId":36455,"journal":{"name":"Russian Journal of Clinical Ophthalmology","volume":"68 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Russian Journal of Clinical Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32364/2311-7729-2022-22-2-103-107","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 4
Abstract
Aim: to assess the effects of prostaglandin F2a analogues on intraocular pressure (IOP) fluctuations when changing body position. Patients and Methods: thirty-eight patients (50 eyes) with newly diagnosed primary open-angle glaucoma (POAG). Patients were examined before and one month after prescribing travoprost, a prostaglandin F2a analogue. During the examination, IOP was measured by Icare pro rebound tonometry and applanation tonometry (corneal-compensated IOP/ccIOP and Goldmann-correlated IOP/IOPg) in a sitting position. Next, IOP was measured by Icare tonometer twice with a 5-min interval in a supine position. Finally, IOP was measured by Icare tonometry and applanation tonometry (IOPcc, IOPg) in the sitting position. Results: baseline IOPcc, IOPg, and IOP measured by Icare were 25.4±3.2 mm Hg, 25.7±2.3 mm Hg, and 22.9±3.4 mm Hg, respectively. IOP levels (Icare tonometry) in the supine position were 23.7±3.3 mm Hg and 24.0±3.3 mm Hg, respectively. In repeated measurements in the sitting position, IOPcc, IOPg, and IOP measured by Icare were 25.4±3.2 mm Hg, 25.7±2.4 mm Hg, and 22.3±3.4 mm Hg. One month after starting treatment with travoprost, IOPcc, IOPg, and IOP measured by Icare reduced to 18.2±2.7 mm Hg, 18.2±1.8 mm Hg, and 16.6±2.5 mm Hg, respectively. IOP levels (Icare tonometry) in the supine position were 17.3±2.8 mm Hg and 17.2±2.7 mm Hg, respectively. In repeated measurements in the sitting position, IOPcc, IOPg, and IOP measured by Icare were 18.0±2.3 mm Hg, 18.4±1.8 mm Hg, and 16.2±2.5 mm Hg, respectively. When transiting in a supine position, the differences in IOP levels were 0.83±1.04 mm Hg at baseline and 0.77±1.41 mm Hg after one month. When transiting in a sitting position, the differences in IOP levels were 1.66±1.24 mm Hg at baseline and 0.99±0. 98 mm Hg after one month. Conclusion: travoprost as a starting monotherapy for POAG provides a long-lasting IOP reduction and minimizes its fluctuations when changing body position Keywords: glaucoma, intraocular pressure, body position, rebound tonometry, prostaglandin analogue, travoprost. For citation: Antonov A.A., Vostrukhin S.V., Volzhanin A.V. et al. Influence of prostaglandin analogues on intraocular pressure fluctuations in body position change. Russian Journal of Clinical Ophthalmology. 2022;22(2):103–107 (in Russ.). DOI: 10.32364/2311-7729-2022- 22-2-103-107.
目的:探讨前列腺素F2a类似物对体位变化时眼压波动的影响。患者与方法:新诊断原发性开角型青光眼(POAG) 38例(50眼)。患者在开曲伏前列素(一种前列腺素F2a类似物)处方前和处方后一个月接受检查。检查时,采用Icare pro反跳眼压仪和压平眼压仪(角膜代偿眼压/ccIOP和goldmann相关眼压/IOPg)在坐位测量眼压。然后,在仰卧位用Icare眼压仪测量眼压2次,间隔5分钟。最后,采用Icare眼压仪和眼压仪(IOPcc, IOPg)测量坐位眼压。结果:Icare测量的基线IOPcc、IOPg和IOP分别为25.4±3.2 mm Hg、25.7±2.3 mm Hg和22.9±3.4 mm Hg。仰卧位IOP (Icare眼压)分别为23.7±3.3 mm Hg和24.0±3.3 mm Hg。在坐位重复测量时,Icare测得的IOPcc、IOPg和IOP分别为25.4±3.2 mm Hg、25.7±2.4 mm Hg和22.3±3.4 mm Hg。曲伏前列素治疗1个月后,Icare测得的IOPcc、IOPg和IOP分别降至18.2±2.7 mm Hg、18.2±1.8 mm Hg和16.6±2.5 mm Hg。仰卧位IOP (Icare血压计)分别为17.3±2.8 mm Hg和17.2±2.7 mm Hg。在坐位重复测量时,Icare测得的IOPcc、IOPg和IOP分别为18.0±2.3 mm Hg、18.4±1.8 mm Hg和16.2±2.5 mm Hg。当采用仰卧位时,IOP水平的差异在基线时为0.83±1.04 mm Hg,一个月后为0.77±1.41 mm Hg。当以坐姿转换时,IOP水平的差异为基线时的1.66±1.24 mm Hg和0.99±0。一个月后98毫米汞柱。结论:曲伏前列素作为POAG的起始单药治疗可提供持久的IOP降低,并最大限度地减少体位变化时的IOP波动。关键词:青光眼,眼压,体位,反跳眼压测量,前列腺素类似物,曲伏前列素。引证:Antonov a.a., Vostrukhin s.v., Volzhanin A.V.等。前列腺素类似物对体位变化时眼压波动的影响。俄罗斯临床眼科学杂志,2022;22(2):103-107。Doi: 10.32364/2311-7729-2022- 22-2-103-107。